Baxalta US INC.:1276806 [21-015888] glassia (alpha 1-proteinase inhibitor
Ended Purchase Order Awarded
- Contract number
- 75N90021P00727
- Awardee
-
Baxalta US Inc. UEI LT5GEHL2F1K6
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,054
Award facts
- Contract value 100% obligated
- $12,054.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 446110 Pharmacies and Drug Stores
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bannockburn, IL 60015, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N90021P00727?
75N90021P00727 was awarded to Baxalta US Inc. by NIH Clinical Center (National Institutes of Health) on September 17, 2021.
How much is contract 75N90021P00727 worth?
The government has obligated $12,054 on 75N90021P00727.
Was contract 75N90021P00727 competed?
The extent of competition for 75N90021P00727 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award